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ABSTRACT 
Potassium tetraborate (PTB) is a product resulting from the controlled reaction of potassium 
hydroxide, water and boric acid (BA). It is used in many areas of industry such as disinfect-
ant, detergent and treatment of contact lenses. PTB is one of the boron compounds which is 
most commonly used in many areas of industry although very limited information is available 
concerning its toxicity. Therefore, in this study, it is aimed to determine genetic and biochem-
ical effects of PTB in human blood cell cultures (n=4). PTB was added into culture tubes at 
various concentrations (0-1280 µg/ml). Micronucleus (MN) and chromosomal aberration 
(CA) tests were performed for genotoxic damage influences estimation. In addition, biochem-
ical parameters (total antioxidant capacity (TAC) and total oxidative status (TOS) were exam-
ined to determine oxidative effects. The results indicated that all tested concentrations of PTB 
were found to be non-genotoxic. In addition, low concentrations (1.25, 2.5 and 5 µg/ml) of 
PTB caused increases of TAC levels. Furthermore, all concentrations of PTB were not 
changed the TOS levels in cultured human blood cells. Based on these results, in this study it 
has been reported for the first time that PTB is not genotoxic and it increases the antioxidant 
capacity in human peripheral blood lymphocytes. 
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INTRODUCTION 
Boron compounds play important bio-
logical roles including improving arthritis, 
plasma lipid profiles and brain function 
(Colak et al., 2011; Devirian and Volpe, 
2003). So far, boron compounds have at-
tracted much interest with respect to their 
protective effect against free radical dam-
age that may be the cause of many diseases 
including cancer (Barranco and Eckhert, 
2006; Scorei et al., 2008). Furthermore, it 
was found that boron compounds were ca-
pable of protecting against heavy metal tox-
icity in cultured human blood cells (Turkez 
et al., 2012a). Besides, it was reported that 
boron compounds like borax (BX) and BA 
showed antioxidant activity in cultured hu-
man blood cells (Turkez et al., 2007, 
2012b). On the other hand, the cellular and 
genetic toxicity of boron compounds was 
not investigated in mammalian cells, al-
though the effects of boron compounds on 
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reproductive system were studied in detail 
(Bolt et al., 2102; Duydu et al., 2012). Po-
tassium tetraborate (K2B4O7, PTB) is a 
product resulting from the controlled reac-
tion of potassium hydroxide, water and BA. 
It is used in many industrial processes in-
cluding oil (Kazuhiro et al., 2004) and glass 
(Toyoyuki et al., 2003) industries. As far as 
we know, there is no study about genotoxic 
and oxidative potentials of PTB in human 
lymphocytes culture. With this aim, not on-
ly chromosomal aberrations (CA) frequen-
cies but also micronuclei (MN) formations 
have been established as related to the dos-
es of PTB on human blood cultures. More-
over, total antioxidant capacity (TAC) and 
total oxidative status (TOS) assays were 
examined to determine oxidative effects. 
 
MATERIALS AND METHODS 
Experimental design 
The heparinized blood samples were 
collected from four healthy males aged 
from 25 to 30 years old, respectively, non-
smoking, non-alcoholic, not under drug 
therapy and with no recent history of expo-
sure to mutagens. Human peripheral blood 
cultures were set up according to a slight 
modification of the protocol described by 
Evans and O’Riordan (1975). The hepa-
rinized blood (0.5 ml) was cultured in 6 ml 
of culture medium (Chromosome Medium 
B, Biochrom, Berlin, Germany) with 
5 mg/ml of phytohemagglutinin (Bio-
chrom). Potassium tetraborate (K2B4O7, 
CAS Number 12045-78-2) was synthetized 
previously described by Marezio et al. 
(1963) and dissolved in distilled water and 
it was added to the cultures just before in-
cubation in concentrations of 1.25, 2.5, 5, 
10, 20, 40, 80, 160, 320, 640 and 1280 
µg/ml. Each individual blood culture with-
out PTB was studied as a control group. 
The concentrations were selected according 
to the works of Turkez et al. (2007). Mito-
mycin C (MMC; 10-7 M, Sigma-Aldrich®) 
was used as the positive control in CA and 
MN assays. Ascorbic acid (10 μM, Sigma-
Aldrich®) and hydrogen peroxide (25 μM, 
Sigma-Aldrich®) were also used as the pos-
itive controls in TAC and TOS analysis, 
respectively.  
 
Micronuclei (MN) assay  
Human lymphocytes were stimulated by 
potassium tetraborate and cultured for about 
72 h; cytochalasin B (Sigma; final concen-
tration of 6 mg ml-1) 44 h after PTB stimu-
lation was added. MN was scored in 1000 
binucleated cells and the frequency of cells 
with micronuclei was determined (Fenech, 
2000; Turkez et al., 2010). 
 
Chromosomal aberration assay 
Chromosomal aberration (CA) tests 
were performed not only to study the cyto-
toxicity of the material on cells but also to 
determine the aberrations induced by the 
particular material on chromosomes of the 
human lymphocytes cell line. For each 
treatment, 30 well-spreaded metaphases 
were analyzed to detect the presence of 
chromosomal aberrations (Turkez and Sis-
man, 2010).  
 
Biochemical assays 
The levels of TAC and TOS were de-
termined by commercially available kits 
(Rel Assay Diagnostics®, Turkey) in cul-
ture samples. 
 
RESULTS 
Table 1 shows the biochemical data ob-
tained from various concentrations of PTB, 
on human peripheral blood cell cultures. As 
shown from the results presented in Table 
1, 1.25, 2.5 and 5 µg/ml concentrations of 
PTB treatment caused significant increases 
of TAC levels. On the other hand, PTB did 
not change the TOS levels in cultured hu-
man lymphocytes at all concentrations. 
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Table 1: In vitro levels of TAC (as mmol Trolox 
Equiv./L) and TOS (as mmol H2O2 Equiv./L) in 
cultured human lymphocytes maintained in the 
presence of potassium tetraborate (PTB) for 24 h 
Concentrat 
ions 
(µg/ml) 
TAC 
(Trolox Equiv. / 
mmol L) 
TOS 
(H2O2 Equiv. / 
μmol L) 
Control (-) 7.36±0.38b 11.52±3.18a
Control (+) 13.71±0.94f 39.25±5.31b
1.25 10.43±0.41e 11.38±3.17a
2.5 9.83±0.43d 11.34±3.14a
5 8.91±0.46d 11.41±3.15a
10 7.95±0.38c 11.32±2.83a
20 7.34±0.41b 11.33±3.15a
40 7.22±0.36b 11.29±3.21a
80 7.17±0.32b 11.39±3.16a
160 7.21±0.35b 11.36±3.17a
320 7.23±0.37b 11.38±2.98a
640 7.15±0.34b 10.41±2.82a
1280 6.86±0.32b 10.44±3.17a
Values are expressed as mean+SD for four cultures in each 
group. The same column followed by the different super-
script letters present significant differences at the p < 0.05 
level. Ascorbic acid (10 μM, Sigma-Aldrich®) and hydrogen 
peroxide (25 μM, Sigma-Aldrich®) were used as the posi-
tive controls in TAC and TOS analysis, respectively.  
 
Results obtained from the analysis of 
MNs and CAs in human lymphocytes cul-
tured with different PTB concentrations are 
shown in Table 2. PTB at tested concentra-
tions did not induce significant (p<0.05) 
number of MNs and CAs. However, the 
MMC applied culture (as positive control) 
showed about three fold increases of both 
parameters as compared to control group. 
 
Table 2: In vitro levels of TOS (H2O2 Equiv. / 
μmol L-1) in cultured human lymphocytes main-
tained in the presence of potassium tetraborate 
for 24 h 
Concentrations 
(µg/ml) 
MN/1000 cell 
± S.D. 
CAs/cell 
± S.D. 
Control (-) 
Control (+) 
1.82±0.75a 
5.21±1.96b 
0.20±0.03a
0.73±0.87a 
1.25 1.84±0.68a 0.17±0.02a
2.5 1.71±0.71a 0.23±0.04a
5 1.82±0.75a 0.18±0.03a
10 1.88±0.67a 0.16±0.04a
20 1.74±0.64a 0.17±0.04a
40 1.90±0.72a 0.20±0.03a
80 1.72±0.69a 0.21±0.04a
160 1.76±0.73a 0.19±0.02a
320 1.83±0.64a 0.16±0.03a
640 1.82±0.71a 0.15±0.02a
1280 1.91±0.78a 0.15±0.03a
The abbreviations are as described in Table 1. 
DISCUSSION 
Antioxidant capacity has important role 
in daily life of human and animals (Geyi-
koglu et al., 2005; Bohloli et al., 2007; Tur-
kez and Togar, 2010). In the present study, 
for assessing the antioxidant/oxidant effects 
of PTB, total antioxidant capacity (TAC) 
and total oxidant status (TOS) assays were 
performed for the first time. Our results re-
ported that PTB applications at its low con-
centrations (1.25, 2.5 and 5µg/ml) caused 
increase of TAC levels, while TOS level 
were not affected. There is no data in litera-
ture about the antioxidant/oxidant effect of 
different PTB concentrations on cultured 
human lymphocytes cells and any other cell 
lines. The evidence of the previous studies 
suggested that boron compounds have the 
ability of strengthening the tissue antioxi-
dant defences in human and animals (Hunt, 
1994; Pawa and Ali, 2006). In accordance 
with present findings, previous studies have 
shown that boron compounds (such as BA, 
BX, colemanite, ulexite) had antioxidant 
property at lower concentrations than 
40 mg/L (Turkez et al., 2007, 2012a). Be-
sides, Hunt and Idso (1999) stated that bo-
ron prevents oxidative damage by increas-
ing of glutathione and its analogs or by 
supporting the other neutralizing agents. 
Likewise, Pawa and Ali (2006) administrat-
ed BX (4 mg/kg), to rats as a boron source 
followed by administration of thioacetam-
ide (a toxic chemical). As a result they re-
ported that boron may have positive effects 
on the oxidant/antioxidant balance. In addi-
tion, Ince et al. (2010) demonstrated that 
boron supplementation decreases lipid pe-
roxidation and enhances antioxidant de-
fence mechanism. Moreover, it was report-
ed that boron prevents oxidative damage by 
increasing of glutathione and its analogs or 
by supporting the other neutralizing agents 
(Hunt and Idso, 1999).  
In this study, genotoxicity assessments 
were carried out using CAs and MN tests to 
provide more safety information on PTB. 
There were no significant differences in the 
incidence of chromosomal aberrations, even 
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after a 72 h treatment with the all concen-
tration of PTB. Also, the tested PTB was 
shown to lack mutagenic activity in cul-
tured human lymphocytes when assessed 
for induction of DNA damage in the MN 
assay. In parallel to our finding, Turkez and 
Geyikoglu (2006) studied the mutagenic 
properties of some boron compounds in 
cultured human lymphocytes. They report-
ed that the used boron compounds did not 
change the SCE frequencies or MN for-
mations. In addition, negative results in a 
large number of mutagenicity assays indi-
cate that boron compounds especially BA 
and BX are not genotoxic (Turkez et al., 
2007). In the same way, Geyikoglu and 
Turkez (2008) and Turkez (2008) reported 
that BA and BX showed protective activity 
against vanadium (IV) tetraoxide and tita-
nium dioxide induced DNA damage on pe-
ripheral lymphocytes. Besides, it was found 
that the dramatic reduction of aflatoxin B1 
(AFB1)-induced SCEs and MN formations 
were due to the protective roles of BX 
(Turkez et al., 2012b). Furthermore, Turkez 
et al. (2013) studied the protective role of 
BX on genotoxicity induced by aluminum 
(Al) in rat liver, using liver MN assay as an 
indicator of genotoxicity. They have report-
ed that BX has beneficial influences and 
has the ability to antagonize Al toxicity. On 
the other hand, recent studies reported that 
BX was found to be genotoxic in human 
lymphocyte cells (Pongsavee, 2009). 
In conclusion, the present study has 
clearly demonstrated that PTB has anti-
oxidative and non-genotoxic activities for 
the first time. However, further studies are 
needed to further elucidate the mechanisms 
of PTB to improve our understanding of 
their antioxidant effect using in vivo and in 
vitro different cell models. 
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